Skip to content

CytomX Therapeutics, Inc.: revenue

Revenue for CytomX Therapeutics, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All CytomX Therapeutics, Inc. financial histories

What this measure means

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2013-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Revenue in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
2025-01-012025-12-3176,201,000USD2026-03-1610-K · 0001193125-26-107146
2024-01-012024-12-31138,103,000USD2026-03-1610-K · 0001193125-26-107146
2023-01-012023-12-31101,214,000USD2025-03-0610-K · 0000950170-25-034575
2022-01-012022-12-3153,163,000USD2024-03-1110-K · 0000950170-24-029191
2021-01-012021-12-3137,312,000USD2023-03-2710-K · 0000950170-23-009991
2020-01-012020-12-3168,427,000USD2023-03-2710-K/A · 0000950170-23-009984
2019-01-012019-12-3126,902,000USD2023-03-2710-K/A · 0000950170-23-009984
2018-01-012018-12-3159,502,000USD2021-02-2410-K · 0001564590-21-008081
2017-01-012017-12-3171,623,000USD2020-02-2710-K · 0001564590-20-007395
2016-01-012016-12-3115,043,000USD2019-02-2710-K · 0001564590-19-004890
2015-01-012015-12-317,712,000USD2018-03-0710-K · 0001564590-18-004727
2014-01-012014-12-315,077,000USD2017-03-0210-K · 0001564590-17-003229
2013-01-012013-12-31888,000USD2016-03-0710-K · 0001564590-16-014091

Related financial histories

Inspect the source

Entity
CytomX Therapeutics, Inc. / CIK 0001501989
Captured
2026-09-20T09:11:45.284Z
SEC response SHA-256
5b42506ede2a678f55147a208e23021683fa4501c0a8daefcc1079a51395cbde

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001501989.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))